Digital Pathology Market Scope And Analysis

Digital Pathology Market Report Scope

Industry Developments and Future Opportunities: 

Various initiatives taken by key players operating in the global digital pathology market are listed below:

1. In June 2022, SpIntellx, Inc., and Inspirata collaborated to integrate the SpIntellx HistoMapr-Breast platform and Inspirata’s Dynamyx software into a seamless solution. HistoMapr-Breast is the only computational pathology software that taps the power of explainable artificial intelligence (xAI) for healthcare providers to diagnose, prognosticate and treat breast cancer more accurately and efficiently.
2. In June 2022, Roche got CE-IVD approval, marking the next-generation Ventana DP 600 slide scanner for digital pathology.
3. In May 2020, Danahar (Leica Biosystems) launched the Aperio GT 450 DX, its next generation digital pathology scanner, in the APAC region. With continuous loading, no-touch operation, and 32 second scan time at 40x magnification, the Aperio GT 450 DX, registered as CE IVD and TGA, allows healthcare organizations to scale up digital pathology so they can meet ever-increasing demands without sacrificing quality.
4. In July 2020, three key members of 3DHISTECH’s PANNORAMIC scanner range, PANNORAMIC 250 Flash III, PANNORAMIC Scan II and PANNORAMIC Midi II as well as their control software have been upgraded to even better serve the diverse needs of cancer and pharmaceutical research, molecular and developmental histology, neuroscience and many more.
5. In August 2020, Danahar (Leica Biosystems), a global leader in pathology workflow solutions, announced the European launch of its Aperio GT 450 DX digital pathology scanner. This next generation imaging system was unveiled at the highly successful Leica Biosystems Digital Pathology Virtual Summit and is already installed at the Centre of Excellence at Leeds Teaching Hospitals NHS Trust NHS, UK.
6. In October 2020, Indica Labs, announced the formal launch of an enterprise-wide, cloud-based deployment of Indica Labs’ software within the National Cancer Institute (NCI), including HALO, HALO AI, HALO Link and HALO AP. Accessible to hundreds of users within the NCI, managing millions of digital images, and facilitating the analysis of thousands of images daily, this is the largest single deployment of Indica Labs’ software world-wide.
7. In May 2020, Danahar (Leica Biosystems), the global leader in pathology workflow solutions, and the international medical imaging IT and cybersecurity company, Sectra, announced a collaboration to seek a combined 510(k) clearance from the U.S. Food & Drug Administration (FDA) soon. The goal is for the integrated clinical digital pathology solution to address the clinical needs of enterprise level customers such as academic medical centers, clinical research organizations and large hospital networks.

Competitive Landscape and Key Companies:

Some of the prominent players digital pathology companies include Koninklijke Philips N.V., Nikon Corporation, Perkin Elmer, Inc., Indica Labs, 3DHISTECH Ltd., Danaher, Hamamatsu Photonics K.K., F. HOFFMANN-LA ROCHE LTD., Visiopharm A/S, and Glencoe Software, Inc among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their digital pathology market share.